Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.180
-0.020 (-1.67%)
May 23, 2025, 4:00 PM - Market closed

Climb Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
19.1715.399.8918.9212.352.43
Upgrade
Research & Development
27.8511.6111.5826.2123.329.34
Upgrade
Operating Expenses
47.022721.4745.1435.6711.77
Upgrade
Operating Income
-47.02-27-21.47-45.14-35.67-11.77
Upgrade
Interest & Investment Income
7.727.382.291.20.45-
Upgrade
Currency Exchange Gain (Loss)
-0.03-0.010.54-1.48-0.170.26
Upgrade
Other Non Operating Income (Expenses)
-----11.72-
Upgrade
EBT Excluding Unusual Items
-39.33-19.64-18.64-45.42-47.11-11.51
Upgrade
Merger & Restructuring Charges
-3.36-3.36-18.81---
Upgrade
Gain (Loss) on Sale of Investments
1.360.762.330.18-0.37-
Upgrade
Pretax Income
-92.98-73.9-35.12-45.24-47.48-20.67
Upgrade
Net Income
-92.98-73.9-35.12-45.24-47.48-20.67
Upgrade
Preferred Dividends & Other Adjustments
----4.552.29
Upgrade
Net Income to Common
-92.98-73.9-35.12-45.24-52.03-22.95
Upgrade
Shares Outstanding (Basic)
58482726122
Upgrade
Shares Outstanding (Diluted)
58482726122
Upgrade
Shares Change (YoY)
113.10%78.47%2.57%114.60%460.40%31.72%
Upgrade
EPS (Basic)
-1.60-1.53-1.30-1.72-4.24-10.49
Upgrade
EPS (Diluted)
-1.60-1.53-1.30-1.72-4.24-10.49
Upgrade
EBIT
-47.02-27-21.47-45.14-35.67-11.77
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q